Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiesse® Post Approval Safety Study For the Treatment of Hands With Moderate to Very Severe Dorsal Volume Loss

NCT02904096 is registered in ClinicalTrials.gov with Merz North America, Inc. as lead sponsor.

NCT NCT02904096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02904096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiesse® Post Approval Safety Study For the Treatment of Hands With Moderate to Very Severe Dorsal Volume Loss
Lead sponsor
Merz North America, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 10, 2016
Completion date
January 9, 2019
Enrollment
256 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

volume loss in the dorsum of the hand